Atalafoline is primarily investigated for its potential neuroprotective and cognitive-enhancing properties. It has shown promise in preclinical studies for supporting neuronal health and improving memory function, particularly in models associated with neurodegenerative conditions such as Alzheimer’s disease. The compound appears to modulate key neurotransmitter systems and may influence synaptic plasticity, which is critical for learning and memory. Additionally, atalafoline has been explored for its anti-inflammatory effects in the central nervous system, suggesting possible utility in managing neuroinflammation. Research is ongoing to determine its efficacy and safety for therapeutic use in neurological and psychiatric disorders.